Cboe files to list staked Injective ETF from Canary Capital

Key Points

1. The Chicago Board Options Exchange (CBOE) submitted a 19b-4 filing to list shares of Canary Capital’s proposed staked Injective ETF.

2. If approved, this would be the third staked altcoin ETF, after staked Solana and Ether ETFs were approved on June 30.

3. The SEC has not yet formally acknowledged the filings, and the review process could take up to 240 days, with a final decision potentially delayed until March 2026.

4. In May, the SEC ruled that staking does not violate securities laws, a decision seen as a 'major step forward' for the crypto industry.

5. If approved, the Injective ETF could provide traditional investors exposure to INJ, potentially helping the token recover from its current price, which is over 71% below its all-time high.